Outpatient medication use and health outcomes in post-acute coronary syndrome patients

American Journal of Managed Care

Volumn 12, Issue 10, 2006, Pages 581-587

  Yang, Zhou ^a   Olomu, Ade ^b   Corser, William ^c   Rovner, David R ^b   Holmes Rovner, Margaret ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; DRUG USE; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SELF REPORT; UNITED STATES;

AGED; AMBULATORY CARE; FEMALE; HUMANS; INTERVIEWS; MALE; MEDICAL AUDIT; MICHIGAN; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PROSPECTIVE STUDIES;

EID: 33750488753     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Braunwald E, Antman EM, Beasle JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2002;16:1893-1900.
2. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-2372.
3. Eagle KA, Klinge-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73-81.
4. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
5. Frilling B, Schiele R, Gitt A, et al. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: results from the MITRA study. Am Heart J. 2004;148:306-311.
6. McCormick D, Curwitz JH, Darleen L, et al. Use of aspirin, beta-blockers, and lipid-lowering medication before recurrent acute myocardial infarction. Arch Intern Med. 1999;159:561-567.
7. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
8. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
9. Lappe JM, Muhlestein JB, Lappe DL, et al. Improvement in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med. 2004;141:446-453.
10. Muhlestein JB, Horne BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 2001;87:257-261.
11. Bradley EH, Herrin J, Mattera JA, et al. Quality improvement efforts and hospital performance: rates of beta blocker prescription after acute myocardial infarction. Med Care. 2005;43:282-292.
12. Bradley EH, Herrin J, Mattera JA, et al. Hospital-level performance improvement: beta-blocker use after acute myocardiai infarction. Med Care. 2004;42:591-599.
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
14. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
15. Frasure-Smith N, Lesperance F. Gender, depression and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26-37.
16. Hlatky MA, Boineau RE, Higginbotham MB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651-654.
17. Kaul P, Armstrong PW, Fu V, et al. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy. Can J Cardiol. 2004;20:760-766.
18. Koch CG, Khandwala F, Cywinski JB, et al. Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg. 2004;128:284-295.
19. Rankin SH. Women recovering after acute myocardial infarction: psychological and physical functioning outcomes for 12 months after acute myocardial infarction. Heart Lung. 2002;31:399-410.
20. Olson MB, Kelsy SF, Matthews K, et al. Symptoms, myocardial ischemia, and quality of life in women: results from the NHLBI-sponsored WISE study. Eur Heart J. 2003;23:1506-1514.
21. Hillers TK, Davis D, Frech F, et al. Quality of life after myocardial infarction. J Clin Epidemiol. 1994;47:1287-1296.
22. Reiffel JA. Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clin Cardiol. 2005;28:128-137.
23. Esep JD, Mehta SK, Uddin F, et al. Beta-blocker therapy in patients with heart failure in the urban setter: moving beyond clinical trials. Am Heart J. 2005;148:958-963.
24. Witham MD, Gillespie ND, Struthers AD. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. Age Ageing. 2004;33:467-472. Epub 2004 June 24.
25. Hlatcky M, Boothroyd D, Melsop K, et al. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation. 2004;110:1960-1966.
26. Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745-749.